You have access
Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Trastuzumab Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide for HER2-positive Operable Breast Cancer: A Multicenter Phase II Trial
SHINYA TOKUNAGA, TSUTOMU TAKASHIMA, SHINICHIRO KASHIWAGI, SATORU NODA, HIDEMI KAWAJIRI, MAO TOKUMOTO, SHIGEHIKO NISHIMURA, TAKEO NISHIMORI, KATSUMI IKEDA, YOSHINARI OGAWA, YOKO MIZUYAMA, TAKESHI SUNAMI, KENJI TEZUKA, SHIGEHITO YAMAGATA, TETSURO ISHIKAWA, SHINZOH KUDOH, MINORU TAKADA, KOSEI HIRAKAWA and MASAICHI OHIRA
Anticancer Research April 2019, 39 (4) 2053-2059; DOI: https://doi.org/10.21873/anticanres.13316